Addictions, Drug & Alcohol Institute
Addictions, Drug & Alcohol Institute > ADAI Publications

ADAI Publications

1331 publications found

  1. Sladky M, Banta-Green C. Kratom & 7-OH: What do we know about use, safety, and overdose risk? Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, April 2024, updated August 2025.
  2. Paschen-Wolff MM, Campbell ANC, Vasquez A, Kessler J, Jansen K, Arnatt CP, Rosa C, Hebden HM, Radin S, Stately A, Shaw J, Kennedy F, Matthews AG, Venner KL. Conducting an implementation intervention study with American Indian and Alaska native communities: Methodological considerations. Contemporary Clinical Trials 2025:107992. [doi: 10.1016/j.cct.2025.107992] PMID: 40544955
  3. Reiman A, Lessin B. Harm Reduction Approaches with Adolescents Who Use Substances. Routledge, 2025, 172p.
  4. Roll J, Barbosa-Leiker C, Carlini B, Fuchs R, McDonell M, Stella N, Riordan DG, Dyedov R, Ellioff K, Reid S. Cannabis Research in Washington State: A Report for the Washington State Department of Commerce. Seattle, WA: Washington State Academy of Sciences, January 2025, 24 p.
  5. Dillard DA, Hebert LE, Dirks LG, Shaw JL, Trinidad SB, Lillie K, Donovan DM, Burke W, Ludman EJ. Attitudes about alcohol misuse among Alaska Native people in a Tribal health care system. Journal of Addiction Medicine 2025 (in press). [doi: 10.1097/ADM.0000000000001564] PMID: 40928084
  6. Le MH, Laschober TC, Tross S, Paschen-Wolff M, Ertl MM, Wright L, Hatch MA. Attitudes toward and experience with naloxone among people who use drugs in the Southeastern United States. International Journal of Drug Policy 2025;139:10479. [doi: 10.1016/j.drugpo.2025.104769] PMID: 40073718
  7. Cooke A, Stack E, Peng L, Cook R, Hartzler B, Leichtling G, Hildebran C, Leahy JM, Payne KS, Kunkel LE, Hoffman K, Korthuis PT. The peers expanding engagement in stimulant harm reduction with contingency management study: A protocol paper. Addiction Science & Clinical Practice 2025;20:48. [doi: 10.1186/s13722-025-00577-8] PMID: 40495203 PMCID: PMC12150483
  8. Simon CB, Hus C, Prado MG, West II, Kwun CGC, LeMaster JW, Hatch MA, Tong ST, Stephens KA. Examining removal of federal waiver restrictions to prescribing buprenorphine in primary care. Journal of the American Board of Family Medicine 2025;38(3):752-756. [doi: 10.3122/jabfm.2024.240453R1] PMID: 41115754
  9. Lovett K, Zatzick D, Palnikas LA, Engstrom A, Nye E, Field C, McGovern M, Parrish C, Banta-Green CJ, Whiteside LK. Adapting to the fentanyl epidemic: Rapid qualitative observations and derived clinical and research implications from the Emergency Department Longitudinal Integrated Care (ED-LINC) randomized clinical trial. Psychiatry 2025;88(4):333-350. [doi: 10.1080/00332747.2025.2472429] PMID: 40100166
  10. ADAI, Research with Expert Advisors on Drug Use (READU), Owens M. The Community-Law Enforcement Aligning in Response to Substance use (CLEARS) Project. Summary of Process Evaluation Findings. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, June 2025, 28 p.
  11. Ertl MM, Woodhouse C, Meche D, Forrest DW, Fegley J, Paschen-Wolff M, Laschober TC, Hatch MA, Nelson CM, Wright L, Tross S. Using structural modeling to examine barriers and facilitators of HIV pre-exposure prophylaxis willingness and length of use in men who have sex with men who use substances in eight Southern U.S. cities. AIDS Patient Care and STDS 2025;39(6):245-256. [doi: 10.1089/apc.2025.0036] PMID: 40401366 PMCID: PMC12172640
  12. Lancaster C, Laschober TC, Nelson CM, Hatch MA, Paschen-Wolff MM, Ertl MM, Wright L, Tross S. Predicting willingness to use MOUD: An application of the theory of reasoned action and theory of planned-behavior. Journal of Drug Issues 2025 (in press). [doi: 10.1177/00220426251395179]
  13. Peng L, Stack E, Cooke A, Hartzler B, Cook R, Leichtling G, Hildebran C, Leahy J, Smith Payne K, Kunkel L, Hoffman K, Korthuis PT. Centering peers in design and training for a peer-delivered contingency management program for self-identified harm reduction and treatment goals. Harm Reduction Journal 2025;22(suppl 1):72. [doi: 10.1186/s12954-025-01213-z] PMID: 40329274 PMCID: PMC12057027
  14. Ball A, Winstead T, Singh S, Floyd A, Banta-Green C. Adolescent and young adult access to opioid use disorder care. Pediatrics 2025;156(1):e2024070224. [doi: 10.1542/peds.2024-070224] PMID: 40499923
  15. Orozco K, Laschober TC, Tross S, Ertl MM, Paschen-Wolff MM, Nelson CM, Lancaster C, Hatch MA. Future pandemic preparedness: conceptualizing vaccine willingness in drug-using populations during COVID-19 in Southeastern U.S. cities. Journal of HIV/AIDS & Social Services 2025 (in press). [doi: 10.1080/15381501.2025.2591675]
  16. Perkins T, Lee B, Mackin J, Donovan D, Rushing SC, Caughlan C, Gchachu Kakuska A, Walker L. Healing of the Canoe: Preliminary suicide prevention outcomes among participating and non-participating youth. Prevention Science 2025;26:740-750. [doi: 10.1007/s11121-025-01806-x] PMID: 40289054
  17. Petersky S, Banta-Green C. Perceptions of Substance Use in Permanent Supportive Housing: Results from the 2024 WA State PerCH Staff Survey. Seattle, WA: Addictions, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, School of Medicine, University of Washington, March 2025, 10p.
  18. Paschen-Wolff MM, Tross S, Nelson CM, Hatch MA, Meche D, Ertl MM, Wright L, Laschober TC. Factors associated with PrEP awareness and use among men who have sex with men who use drugs in the Southern United States. AIDS Care 2025;37(1):21-32. [doi: 10.1080/09540121.2024.2438923] PMID: 39651544
  19. Owens MD, Adwell A, Singh S, Osilla K, Tweedy M, Tsui J. “All I want is the best for my brother”: Interest in a Community Reinforcement and Family Training (CRAFT)-based group intervention among concerned significant others of individuals on office-based medications for opioid use disorder. BMC Psychiatry 2025;25:748. [doi: 10.1186/s12888-025-07132-4] PMID: 40745287 PMCID: PMC12312360
  20. Hatch MA, Ertl M, Closs D, Keeshin S, Feinberg J, Orozco K, Tross S. HIV prevention in syringe service programs since the start of COVID-19: Where do we go from here? Current HIV/AIDS Reports 2025;22(1):13. [doi: 10.1007/s11904-024-00721-0] PMID: 39812953 PMCID: PMC12640190